UNSPSC 51162706: Carbocisteine

This classification denotes a mucolytic agent with the molecular formula C5H9NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 740J2QX53R, chemically known as (rs)-cysteine, s-(carboxymethyl)- but more generally known as carbocisteine, which bears US NIH Compound Identifier 1080. European Medicines Agency schedules Carbocisteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11790MIG.

World Health Organization schedules carbocisteine in its Anatomical Therapeutic Chemical (ATC) Classification. CARBOCISTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule carbocisteine under HS 29309016 and SITC 51549. SMILES: SCC(N)C(=O)O.

UNSPSC 51162706 Carbocisteine is a Commodity code that in recent state and local solicitations covers pharmaceutical products including naloxone, drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products supplied through authorized wholesalers to government health facilities and community health programs. State and local buyers under this code include county health departments, state procurement offices administering cooperative purchasing alliances, and participating state and local government facilities across multiple jurisdictions. The work spans both emergency response pharmaceuticals (naloxone for opioid overdose intervention) and routine supply of generic medications and OTC products to government health systems, with vendors responsible for sourcing, quality compliance, pricing submission, and delivery logistics.

Recent activity centers on Florida and Minnesota-led multi-state cooperative purchasing. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, requiring electronic bid submission and E-Verify compliance. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota, Oregon, and other member jurisdictions, with products to be available through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) effective July 1, 2026. Both solicitations require FDA compliance, cGMP certification, comprehensive insurance coverage, and demonstrated supply-chain security credentials.